Sermorelin vs Epithalon
A comprehensive, data-driven comparison of Sermorelin (GHRH 1-29) and Epithalon (Epitalon). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Sermorelin GHRH 1-29, GRF 1-29 | Epithalon Epitalon, Epithalone |
|---|---|---|
| FDA Status | Withdrawn (off-label use continues) | Not submitted |
| Category | Growth Hormone | Anti-Aging |
| Primary Use | Growth hormone deficiency and anti-aging | Anti-aging and longevity research |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $150 - $350/mo | $40 - $80/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 200-500mcg daily before bed | 5-10mg per cycle (10-20 days, 2-3x per year) |
| Frequency | Daily | Cyclical |
| Mechanism | Bioidentical analog of growth hormone releasing hormone (GHRH) that stimulates natural GH production | Tetrapeptide that may activate telomerase enzyme to lengthen telomeres and potentially extend cellular lifespan |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Moderate | Emerging |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1Epithalon is generally more affordable ($40 - $80/mo) compared to Sermorelin ($150 - $350/mo).
- 2Sermorelin is dosed daily, while Epithalon is cyclical.
- 3Sermorelin has moderate-quality evidence, while Epithalon has emerging-quality evidence.
- 4They belong to different categories: Sermorelin (Growth Hormone) vs Epithalon (Anti-Aging).
Which Is Better For...
Epithalon
More budget-friendly option with lower monthly costs
Epithalon
More convenient dosing schedule (cyclical)
Epithalon
Fewer commonly reported side effects
Sermorelin
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Sermorelin | $150 - $350/mo | Withdrawn (off-label use continues) | Various research labs |
| Epithalon | $40 - $80/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Sermorelin works via Bioidentical analog of growth hormone releasing hormone (GHRH) that stimulates natural GH. Epithalon works via Tetrapeptide that may activate telomerase enzyme to lengthen telomeres and potentially extend. They differ in FDA approval status, efficacy data, and cost.
Sermorelin typically costs $150 - $350/mo, while Epithalon costs $40 - $80/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Sermorelin is not FDA-approved (Withdrawn (off-label use continues)). Epithalon is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Sermorelin include Injection site reactions, Flushing, Headache. Common side effects of Epithalon include Injection site reactions, Mild drowsiness, Vivid dreams. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Sermorelin is a bioidentical synthetic version of growth hormone releasing hormone (GHRH) consisting of the first 29 amino acids of the full 44-amino acid GHRH molecule. It was previously FDA-approved...
View Full Sermorelin GuideEpithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) researched primarily in Russia for its potential anti-aging properties. The proposed mechanism involves activation of telomerase, an enzyme that...
View Full Epithalon GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Sermorelin and Epithalon should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.